Healthcare

An article published in Experimental Biology and Medicine identifies a new target for the treatment of idiopathic pulmonary fibrosis.
Current cancer control efforts in the United States typically are fragmented and uncoordinated, but taking a systems approach to establish a U.S. National Cancer Control Plan would address the challenge more holistically, says a new report from the National Academies of Sciences, Engineering, and Medicine.
Driving personalized, immune-based therapy to target patients’ own immune responses
Vivoryon Therapeutics AG, announced that they have entered into a research collaboration with University Medical Center Schleswig-Holstein, Campus Kiel, to discover and develop first-in-class therapeutics in cancer immunotherapy.
Hacarus Inc, the leading provider of lightweight and explainable AI, was awarded the Grand Prize by DS Pharma Animal Health for its innovative AI-enabled technology platform ‘HACARUS.ai’
CENTOGENE biomarker measures lyso-Gb1 levels in children
Admedus Ltd announces the publication of an independent study assessing the performance of CardioCel® in the prestigious peer-reviewed journal, The Annals of Thoracic Surgery.
The company will focus on chemoproteomics, which it calls a way of interrogating proteins in living systems. This allows them to identify potential new binding targets on proteins, which will allow the development of small-molecule drugs.
City of Hope announced plans to build a new comprehensive cancer campus at FivePoint Gateway in Orange County. As part of that plan, it will invest more than $1 billion into the project.
The data indicated that some surgeons prescribed more than 100 opioid pills for the week after a surgery. However, current guidelines from several academic medical centers called for zero to 10 pills for many of the procedures analyzed, with up to 30 for coronary bypass surgery.
PRESS RELEASES